| Stage | MIR | % of rev | TMO | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $278M | 100.00% | $12.1B | 100.00% | TMO ×43.69 |
| Gross profit | $132M | 47.34% | $5.1B | 42.28% | MIR +5.1pp |
| Operating income | $17M | 6.19% | $2.3B | 18.65% | TMO +12.5pp |
| Pre-tax income | $11M | 3.92% | $2.1B | 17.20% | TMO +13.3pp |
| Net income | $8M | 2.81% | $1.7B | 14.23% | TMO +11.4pp |
| Stage | MIR | TMO | Gap · A − B |
|---|---|---|---|
| Revenue | $278M100.00% | $12.1B100.00% | TMO ×43.69 |
| Gross profit | 47.34%$132M | 42.28%$5.1B | MIR +5.1pp |
| Operating income | 6.19%$17M | 18.65%$2.3B | TMO +12.5pp |
| Pre-tax income | 3.92%$11M | 17.20%$2.1B | TMO +13.3pp |
| Net income |
| 2.81%$8M |
| 14.23%$1.7B |
| TMO +11.4pp |
None
No disclosed counterparties: MIR.